組換えDNA技術の世界市場規模調査・予測：製品別、コンポーネントタイプ別、用途別、最終用途別、地域別分析、2023-2030年

組換えDNA技術は、主に、遺伝子的に変更されたベクターを生物のゲノムに導入して統合した後、生物（宿主）の表現型を変更するために使用される方法です。

この手順は基本的に、目的の遺伝子を含むゲノムに見慣れないDNA構造の一部を導入することを伴います。組換えDNA技術は、新しく開発された組換え遺伝子を作り出すために用いられます。組換えDNA技術では、望ましい結果を生み出すために、いくつかの技術、装置、およびその他の特定の手順を使用して人工DNAを生成します。政府の取り組みの高まり、組換えインスリンの出現の増加、組換え/遺伝子組換え製品の需要の急増、さらに慢性疾患の有病率の上昇が、世界中で市場の需要を押し上げている最も顕著な要因です。

さらに、バイオ医薬品産業の急速な拡大が、世界市場の拡大に重要な役割を果たしています。バイオ医薬品とは、生物を利用して製造される医薬品であり、その多くは組換えDNA技術を用いて開発されます。Statistaによると、2022年、バイオ医薬品セクターは全世界で4,031億米ドルを占めると推定され、今後も絶えず増加し、2030年には9,745億米ドルに達すると予測されています。また、rDNA技術の継続的な進歩により、組換えDNA分子の形成が可能になり、バイオ医薬品研究に新たな機会が生まれています。この技術の採用は、強力なバイオ医薬品パイプライン、特に組換えタンパク質のパイプラインの存在によって促進されると予想されます。この市場の拡大は、CRISPR/Cas9ヌクレアーゼ、ZFN、TALENと組み合わせたrDNA技術を用いた組換え製品の開発が、生物による制約を受けずにシンプルかつ正確なゲノム編集を可能にしたことに大きく起因しています。研究者によって実施された数多くのレビュー研究により、rDNA技術の有効性が実証されています。さらに、ゲノミクスの技術的進歩、研究開発イニシアチブの高まり、市場参入企業による戦略的提携は、予測される数年間にさまざまな有利な機会をもたらします。しかし、遺伝子組換え食品の使用に伴うリスクや、遺伝子治療に関連する規制、科学的、倫理的な課題が、2023～2030年の予測期間を通じて市場の成長を妨げています。

組換えDNA技術の世界市場調査において考慮した主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカが含まれます。北米は、研究開発活動の成長とともに、バイオ医薬品製造企業の増加により、2022年の市場を独占しました。例えば、2022年5月、PharmaJetは、米国国立衛生研究所（NIH）の国立老化研究所（NIA）が、そのパートナーである分子医学研究所（IMM）に1,200万米ドルの賞を授与したと発表しました。この賞は、アルツハイマー病（AD）の治療と予防のための、組換えタンパク質とDNAに基づくベータアミロイドワクチンの開発に資金を提供するものです。こうした研究が市場の拡大を加速させています。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されています。低コストの製造センターの存在、この技術の利点に関する意識の高まり、患者数の増加、多くの政府組織による投資の増加が、この地域の市場需要を大きく促進しています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界市場・セグメント別市場推計・予測、2020-2030年
  • 組換えDNA技術市場：地域別、2020-2030年
  • 組換えDNA技術市場：製品別、2020-2030年
  • 組換えDNA技術市場：コンポーネントタイプ別、2020-2030年
  • 組換えDNA技術市場：用途別、2020-2030年
  • 組換えDNA技術市場：最終用途別、2020-2030年
• 主要動向
• 調査手法
• 調査前提条件

第2章 組換えDNA技術の世界市場定義とスコープ

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 組換えDNA技術の世界市場力学

• 組換えDNA技術市場のインパクト分析（2020～2030年）
  • 市場促進要因
    • バイオ医薬品産業の急速な拡大
    • 組換え/遺伝子組換え製品に対する需要の急増
  • 市場の課題
    • 遺伝子組換え食品の使用に伴うリスク
    • 遺伝子治療に関連する規制上、科学上、倫理上の課題
  • 市場機会
    • ゲノミクスの技術的進歩
    • 市場プレイヤーによる研究開発イニシアチブの高まりと戦略的提携

第4章 組換えDNA技術の世界市場の産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 組換えDNA技術の世界市場：製品別

• 市場スナップショット
• 組換えDNA技術の世界市場：製品別、業績 - ポテンシャル分析
• 組換えDNA技術の世界市場：製品別、推定・予測、2020～2030年
• 組換えDNA技術市場、サブセグメント別分析
  • 医療用
  • 非医療用

第6章 組換えDNA技術の世界市場：コンポーネントタイプ別

• 市場スナップショット
• 組換えDNA技術の世界市場：コンポーネントタイプ別、業績 - ポテンシャル分析
• 組換えDNA技術の世界市場：コンポーネントタイプ別、推定・予測、2020-2030年
• 組換えDNA技術市場、サブセグメント別分析
  • 発現システム
  • クローニングベクター

第7章 組換えDNA技術の世界市場：用途別

• 市場スナップショット
• 組換えDNA技術の世界市場：用途別、業績 - ポテンシャル分析
• 組換えDNA技術の世界市場：用途別、推定・予測、2020～2030年
• 組換えDNA技術市場、サブセグメント分析
  • 食品・農業
  • ヘルス・疾患
  • 環境
  • その他

第8章 組換えDNA技術市場：最終用途別

• 市場スナップショット
• 組換えDNA技術の世界市場：最終用途別、業績 - ポテンシャル分析
• 組換えDNA技術の世界市場：最終用途別、推定・予測、2020-2030年
• 組換えDNA技術市場、サブセグメント分析
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • その他

第9章 組換えDNA技術の世界市場：地域別分析

• 主要国
• 主な新興国
• 組換えDNA技術市場、地域別市場スナップショット
• 北米
  • 米国
    • 製品タイプ別、推定・予測、2020-2030年
    • コンポーネントタイプ別、推定・予測、2020-2030年
    • アプリケーション別、推定・予測、2020-2030年
    • 最終用途別、推定・予測、2020-2030年
  • カナダ
• 欧州の組換えDNA技術市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋の組換えDNA技術市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの組換えDNA技術市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東・アフリカ

第10章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • F. Hoffmann-La Roche Ltd（Genentech, Inc）
    • 主要情報
    • 概要
    • 財務（データの入手が可能な場合）
    • 製品概要
    • 最近の動向
  • Profacgen
  • Amgen Inc
  • Novartis AG
  • GenScript
  • Pfizer Inc
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Merck & Co., Inc.

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Recombinant DNA Technology Market, report scope
• TABLE 2. Global Recombinant DNA Technology Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3. Global Recombinant DNA Technology Market estimates & forecasts by Product 2020-2030 (USD Billion)
• TABLE 4. Global Recombinant DNA Technology Market estimates & forecasts by Component Type 2020-2030 (USD Billion)
• TABLE 5. Global Recombinant DNA Technology Market estimates & forecasts by Application 2020-2030 (USD Billion)
• TABLE 6. Global Recombinant DNA Technology Market estimates & forecasts by End-use 2020-2030 (USD Billion)
• TABLE 7. Global Recombinant DNA Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Recombinant DNA Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Recombinant DNA Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Recombinant DNA Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Recombinant DNA Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Recombinant DNA Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Recombinant DNA Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Recombinant DNA Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. Global Recombinant DNA Technology Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. Global Recombinant DNA Technology Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17. U.S. Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 18. U.S. Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19. U.S. Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 20. Canada Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 21. Canada Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22. Canada Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 23. UK Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 24. UK Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25. UK Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 26. Germany Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 27. Germany Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28. Germany Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 29. France Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 30. France Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31. France Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 32. Italy Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 33. Italy Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34. Italy Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 35. Spain Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 36. Spain Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37. Spain Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 38. RoE Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 39. RoE Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40. RoE Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 41. China Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 42. China Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43. China Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 44. India Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 45. India Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46. India Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 47. Japan Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 48. Japan Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49. Japan Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 50. South Korea Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 51. South Korea Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52. South Korea Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 53. Australia Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 54. Australia Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55. Australia Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 57. RoAPAC Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58. RoAPAC Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 59. Brazil Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 60. Brazil Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61. Brazil Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 62. Mexico Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 63. Mexico Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64. Mexico Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 65. RoLA Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 66. RoLA Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67. RoLA Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 68. Saudi Arabia Recombinant DNA Technology Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 69. South Africa Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70. RoMEA Recombinant DNA Technology Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 71. List of secondary sources, used in the study of global Recombinant DNA Technology Market
• TABLE 72. List of primary sources, used in the study of global Recombinant DNA Technology Market
• TABLE 73. Years considered for the study
• TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Recombinant DNA Technology Market, research methodology
• FIG 2. Global Recombinant DNA Technology Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Recombinant DNA Technology Market, key trends 2022
• FIG 5. Global Recombinant DNA Technology Market, growth prospects 2023-2030
• FIG 6. Global Recombinant DNA Technology Market, porters 5 force model
• FIG 7. Global Recombinant DNA Technology Market, pest analysis
• FIG 8. Global Recombinant DNA Technology Market, value chain analysis
• FIG 9. Global Recombinant DNA Technology Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Recombinant DNA Technology Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Recombinant DNA Technology Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Recombinant DNA Technology Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Recombinant DNA Technology Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Recombinant DNA Technology Market, regional snapshot 2020 & 2030
• FIG 15. North America Recombinant DNA Technology Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Recombinant DNA Technology Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Recombinant DNA Technology Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Recombinant DNA Technology Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Recombinant DNA Technology Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Recombinant DNA Technology Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Recombinant DNA Technology is a method primarily used to alter the phenotype of an organism (host) after introducing and integrating a genetically changed vector into the organism's genome. This procedure essentially entails the introduction of an unfamiliar piece of DNA structure into the genome that houses our gene of interest. Recombinant DNA technology is used to create newly developed recombinant genes. Recombinant DNA technology uses several techniques, equipment, and other particular procedures to produce artificial DNA in order to create the desired result. The rising government initiatives, rising emergence of recombinant insulin, surging demand for recombinant/ genetically modified products, coupled with the rising prevalence of chronic diseases are the most prominent factors that are propelling the market demand across the globe.

Additionally, the rapid expansion of the biopharmaceutical industry is playing a significant role in augmenting the global market expansion. Biopharmaceuticals are drugs that are produced using living organisms, and many of them are developed using recombinant DNA technology. According to Statista, in 2022, the biopharmaceuticals sector was estimated to account for USD 403.1 billion across the globe, which is projected to constantly rise and estimated to reach USD 974.5 billion by 2030. Also, the continuous progress of rDNA techniques has created novel opportunities for biopharmaceutical research by enabling the formation of a recombinant DNA molecule. The adoption of this technology is anticipated to be fueled by the presence of a strong biopharmaceuticals pipeline, particularly the pipeline for recombinant proteins. The expansion of this market is largely attributable to the development of recombinant products using rDNA techniques in conjunction with CRISPR/Cas9 nuclease, ZFN, and TALEN enabling simple & accurate genome editing with no constraints by organisms. Numerous review studies conducted by researchers have demonstrated the effectiveness of rDNA technology. Moreover, the technological advancements in genomics, as well as the rising R&D initiatives and strategic collaborations by market players presents various lucrative opportunities over the forecasting years. However, the risks associated with the use of genetically modified food and regulatory, scientific, and ethical challenges related with gene therapy are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Recombinant DNA Technology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing number of biopharmaceutical manufacturing companies, along with growing research and development activities. For instance, in May 2022, PharmaJet announced that the National Institute on Ageing (NIA) branch of the National Institutes of Health (NIH) granted its partner, the Institute for Molecular Medicine (IMM), a USD 12 million award. The award funds the development of beta-amyloid vaccines based on recombinant proteins and DNA for the treatment and prevention of Alzheimer's disease (AD). Such studies are accelerating the market's expansion. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The presence of low-cost manufacturing centers, rising awareness regarding the benefits of this technology, increasing patient pool, as well as rising investments by many government organizations are significantly propelling the market demand across the region.

Major market players included in this report are:

• F. Hoffmann-La Roche Ltd (Genentech, Inc)
• Profacgen
• Amgen Inc
• Novartis AG
• GenScript
• Pfizer Inc
• Novo Nordisk A/S
• Eli Lilly and Company
• Sanofi
• Merck & Co., Inc.

Recent Developments in the Market:

• In March 2022, VBI Vaccines Inc. unveiled the launch of PreHevbrio (Recombinant Hepatitis B Vaccine) for the treatment of individuals 18 years of age and older patients are at risk of contracting any of the identified subtypes of the hepatitis B virus (HBV).
• In February 2022, the 3-antigen hepatitis B (HBV) vaccine manufactured by VBI Vaccines Inc. under the trade name PreHevbri received approval from the European Medicines Agency's Committee for Medicinal Products for Human Use. This vaccine is intended to protect adults from an infection caused by a particular subtype of the hepatitis B virus.

Global Recombinant DNA Technology Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product, Component Type, Application, End-use, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Medical
• Non-medical

By Component Type:

• Expression System
• Cloning Vector

By Application:

• Food & Agriculture
• Health & Disease
• Environment
• Others

By End-use:

• Pharmaceutical & Biotech Companies
• Academic & Research Institutes
• Other

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Recombinant DNA Technology Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Recombinant DNA Technology Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Recombinant DNA Technology Market, by Component Type, 2020-2030 (USD Billion)
  • 1.2.4. Recombinant DNA Technology Market, by Application, 2020-2030 (USD Billion)
  • 1.2.5. Recombinant DNA Technology Market, by End-use, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Recombinant DNA Technology Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Recombinant DNA Technology Market Dynamics

• 3.1. Recombinant DNA Technology Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rapid expansion of the biopharmaceutical industry
    • 3.1.1.2. Surging demand for recombinant/ genetically modified products
  • 3.1.2. Market Challenges
    • 3.1.2.1. Risks associated with the use of genetically modified food
    • 3.1.2.2. Regulatory, scientific, and ethical challenges related with gene therapy
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Technological advancements in genomics
    • 3.1.3.2. Rising R&D initiatives and strategic collaborations by market players

Chapter 4. Global Recombinant DNA Technology Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Recombinant DNA Technology Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Recombinant DNA Technology Market by Product, Performance - Potential Analysis
• 5.3. Global Recombinant DNA Technology Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Recombinant DNA Technology Market, Sub Segment Analysis
  • 5.4.1. Medical
  • 5.4.2. Non-medical

Chapter 6. Global Recombinant DNA Technology Market, by Component Type

• 6.1. Market Snapshot
• 6.2. Global Recombinant DNA Technology Market by Component Type, Performance - Potential Analysis
• 6.3. Global Recombinant DNA Technology Market Estimates & Forecasts by Component Type 2020-2030 (USD Billion)
• 6.4. Recombinant DNA Technology Market, Sub Segment Analysis
  • 6.4.1. Expression System
  • 6.4.2. Cloning Vector

Chapter 7. Global Recombinant DNA Technology Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Recombinant DNA Technology Market by Application, Performance - Potential Analysis
• 7.3. Global Recombinant DNA Technology Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 7.4. Recombinant DNA Technology Market, Sub Segment Analysis
  • 7.4.1. Food & Agriculture
  • 7.4.2. Health & Disease
  • 7.4.3. Environment
  • 7.4.4. Others

Chapter 8. Recombinant DNA Technology Market, by End-use

• 8.1. Market Snapshot
• 8.2. Global Recombinant DNA Technology Market by End-use, Performance - Potential Analysis
• 8.3. Global Recombinant DNA Technology Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
• 8.4. Recombinant DNA Technology Market, Sub Segment Analysis
  • 8.4.1. Pharmaceutical & Biotech Companies
  • 8.4.2. Academic & Research Institutes
  • 8.4.3. Others

Chapter 9. Global Recombinant DNA Technology Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. Recombinant DNA Technology Market, Regional Market Snapshot
• 9.4. North America Recombinant DNA Technology Market
  • 9.4.1. U.S. Recombinant DNA Technology Market
    • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Component Type breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada Recombinant DNA Technology Market
• 9.5. Europe Recombinant DNA Technology Market Snapshot
  • 9.5.1. U.K. Recombinant DNA Technology Market
  • 9.5.2. Germany Recombinant DNA Technology Market
  • 9.5.3. France Recombinant DNA Technology Market
  • 9.5.4. Spain Recombinant DNA Technology Market
  • 9.5.5. Italy Recombinant DNA Technology Market
  • 9.5.6. Rest of Europe Recombinant DNA Technology Market
• 9.6. Asia-Pacific Recombinant DNA Technology Market Snapshot
  • 9.6.1. China Recombinant DNA Technology Market
  • 9.6.2. India Recombinant DNA Technology Market
  • 9.6.3. Japan Recombinant DNA Technology Market
  • 9.6.4. Australia Recombinant DNA Technology Market
  • 9.6.5. South Korea Recombinant DNA Technology Market
  • 9.6.6. Rest of Asia Pacific Recombinant DNA Technology Market
• 9.7. Latin America Recombinant DNA Technology Market Snapshot
  • 9.7.1. Brazil Recombinant DNA Technology Market
  • 9.7.2. Mexico Recombinant DNA Technology Market
• 9.8. Middle East & Africa Recombinant DNA Technology Market
  • 9.8.1. Saudi Arabia Recombinant DNA Technology Market
  • 9.8.2. South Africa Recombinant DNA Technology Market
  • 9.8.3. Rest of Middle East & Africa Recombinant DNA Technology Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. F. Hoffmann-La Roche Ltd (Genentech, Inc)
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. Profacgen
  • 10.3.3. Amgen Inc
  • 10.3.4. Novartis AG
  • 10.3.5. GenScript
  • 10.3.6. Pfizer Inc
  • 10.3.7. Novo Nordisk A/S
  • 10.3.8. Eli Lilly and Company
  • 10.3.9. Sanofi
  • 10.3.10. Merck & Co., Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption